Evidence map›Paper›PMID 31179355›Full record

ArticleVirusdisease2019

Performance evaluation of TRUPCR

Sujata Lall, Manish C Choudhary, Supriya Mahajan, Guresh Kumar, Ekta Gupta

Open access · bronzeAbstract read
In one paragraph

Article in Virusdisease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Comparison of novel DiaRD-HBV DNA qPCR kit with theTurkish journal of medical sciences · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sujata Lall1Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, 110070 India.
Manish C Choudhary1Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, 110070 India.
Supriya Mahajan1Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, 110070 India.
Guresh Kumar2Department of Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, 110070 India.
Ekta Gupta1Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, 110070 India.
Institute of Liver and Biliary Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative Real-time PCR (qPCR) based Hepatitis B virus (HBV) DNA load estimation is crucial for the initiation of treatment and serves as a strong predictor of liver disease progression in HBV infected individuals. HBV DNA quantification has been ever evolving with the addition of new qPCR based kits on a regular basis. The study was carried with an objective to evaluate the performance characteristics of a commercially available qPCR kit (TRUPCR

Indexed as

HBV DNA quantificationReal-time PCRTRUPCR®

Identifiers

PMID31179355
PMCPMC6531600
OpenAlexW2908243760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.